Search results
Earnings call: Novavax strikes multibillion-dollar deal with Sanofi
Investing.com· 22 hours agoThe deal, which includes upfront and milestone payments of around $1.3 billion, half of which is...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 13 hours agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Shah Capital urges Novavax shareholders to vote against three directors
Reuters via Yahoo Finance· 7 days ago(Reuters) -Hedge fund Shah Capital on Monday urged Novavax shareholders to vote against the...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 3 days agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational...
FOX 23 News Albany· 6 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its first quarter ...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 3 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax Shares Surge Over 130% After $1.4 Billion Covid Shot Deal With Sanofi
Forbes· 3 days agoNovavax shares surged 132% to $10.41 as of 10:00 a.m. Friday morning, following an earlier surge in...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 3 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...